Wilmington Savings Fund Society FSB Raises Stake in Colgate-Palmolive (NYSE:CL)

Wilmington Savings Fund Society FSB boosted its holdings in Colgate-Palmolive (NYSE:CL) by 8.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 55,798 shares of the company’s stock after acquiring an additional 4,465 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Colgate-Palmolive were worth $5,073,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. D Orazio & Associates Inc. lifted its holdings in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after acquiring an additional 108 shares during the last quarter. Fiducient Advisors LLC raised its position in Colgate-Palmolive by 5.2% in the third quarter. Fiducient Advisors LLC now owns 2,231 shares of the company’s stock valued at $232,000 after purchasing an additional 110 shares during the period. Sequoia Financial Advisors LLC lifted its stake in Colgate-Palmolive by 0.6% during the third quarter. Sequoia Financial Advisors LLC now owns 20,392 shares of the company’s stock worth $2,117,000 after purchasing an additional 113 shares in the last quarter. Waldron Private Wealth LLC boosted its position in shares of Colgate-Palmolive by 2.1% during the third quarter. Waldron Private Wealth LLC now owns 5,632 shares of the company’s stock worth $585,000 after buying an additional 118 shares during the period. Finally, Commonwealth Financial Services LLC grew its stake in shares of Colgate-Palmolive by 4.5% in the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after buying an additional 118 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.3 %

Shares of CL stock opened at $86.81 on Friday. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The firm’s 50-day simple moving average is $90.36 and its 200-day simple moving average is $96.76. The firm has a market cap of $70.93 billion, a P/E ratio of 24.66, a PEG ratio of 4.12 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the previous year, the business earned $0.87 EPS. As a group, equities analysts forecast that Colgate-Palmolive will post 3.73 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 56.82%.

Analyst Upgrades and Downgrades

CL has been the subject of several recent research reports. UBS Group lowered their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research note on Monday, February 3rd. Stifel Nicolaus reduced their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday, February 3rd. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price objective on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Finally, Barclays decreased their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.